class = “sc-cffd1e67-0 iQNQmc”>
Hershey boss Michele Buck said on US broadcaster CNBC on Thursday that she did not expect any results for the whole of this year. Medicines such as Wegowy or Ozempic reduce appetite and cravings for high-calorie and fatty foods, among other things. Therefore, it is a much debated question how much the widespread use of the drug can affect the business of food companies and the fast food industry.
Buck said Hershey’s (which includes “KitKat” and “Reese’s”) is preparing for potential changes. They are considering smaller pack sizes because people taking such medications want to eat less. The variety of protein products may also be reduced. Snacks become more important to them because they need to compensate for lower nutritional intake.
Sales at Hershey’s North American confectionery business, its largest division, rose 2.1% annually to $2.22 billion in the latest quarter. Groupwide sales were little changed at just under $2.66 billion. Profits fell twelve percent to approximately $349 million. (SDA)
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
